Atlas Trials

RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon Cancer

Clinical trial NCT02466906 · UNKNOWN

Trial details

NCT number
NCT02466906
Sponsor
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colon Cancer
Start date
2015-06-01
Primary completion
2020-06-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.